Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.
Saved in:
| Title: | Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study. |
|---|---|
| Authors: | Kern JS; Monash University School of Translational Medicine and Alfred Health, Melbourne, Victoria, Australia., Thomsen SF; Bispebjerg Hospital, Department of Dermatology, University of Copenhagen, Copenhagen, Denmark., Kokolakis G; Psoriasis Research and Treatment Center, Clinic of Dermatology, Venereology, and Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Podda M; Department of Dermatology, Medical Center Klinikum Darmstadt, Teaching Hospital Goethe-University Frankfurt, Darmstadt, Germany., Jemec GBE; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.; Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.; PHOENIX Center, Department of Allergy, Dermatology and Venereology, Herlev-Gentofte Hospital, Copenhagen, Denmark., Gebauer K; Fremantle Dermatology, Fremantle, Western Australia, Australia., Zachariae C; Department of Dermatology and Allergy, University Hospital of Copenhagen Gentofte, Hellerup, Denmark., Frew J; Holdsworth House Research, Sydney, New South Wales, Australia., Fernandez-Peñas P; Department of Dermatology, The University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia., Bechara FG; Department of Dermatology, Venereology and Allergology, Ruhr-University, Bochum, Germany.; ICH - International Center for Hidradenitis Suppurativa/Acne Inversa, Ruhr-University, Bochum, Germany., Beissert S; Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Malandkar S; CSL Behring, Melbourne, Victoria, Australia., Scalzo-Inguanti K; CSL Behring, Melbourne, Victoria, Australia., Nandy P; CSL Behring, King of Prussia, Pennsylvania, USA., Sukumar S; CSL Behring, King of Prussia, Pennsylvania, USA. |
| Source: | Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2026 Jul 21. Date of Electronic Publication: 2026 Jul 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42478283 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kern+JS%22">Kern JS</searchLink>; Monash University School of Translational Medicine and Alfred Health, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Thomsen+SF%22">Thomsen SF</searchLink>; Bispebjerg Hospital, Department of Dermatology, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kokolakis+G%22">Kokolakis G</searchLink>; Psoriasis Research and Treatment Center, Clinic of Dermatology, Venereology, and Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Podda+M%22">Podda M</searchLink>; Department of Dermatology, Medical Center Klinikum Darmstadt, Teaching Hospital Goethe-University Frankfurt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Jemec+GBE%22">Jemec GBE</searchLink>; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.; Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.; PHOENIX Center, Department of Allergy, Dermatology and Venereology, Herlev-Gentofte Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Gebauer+K%22">Gebauer K</searchLink>; Fremantle Dermatology, Fremantle, Western Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Zachariae+C%22">Zachariae C</searchLink>; Department of Dermatology and Allergy, University Hospital of Copenhagen Gentofte, Hellerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Frew+J%22">Frew J</searchLink>; Holdsworth House Research, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Fernandez-Peñas+P%22">Fernandez-Peñas P</searchLink>; Department of Dermatology, The University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Bechara+FG%22">Bechara FG</searchLink>; Department of Dermatology, Venereology and Allergology, Ruhr-University, Bochum, Germany.; ICH - International Center for Hidradenitis Suppurativa/Acne Inversa, Ruhr-University, Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Beissert+S%22">Beissert S</searchLink>; Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Malandkar+S%22">Malandkar S</searchLink>; CSL Behring, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Scalzo-Inguanti+K%22">Scalzo-Inguanti K</searchLink>; CSL Behring, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Nandy+P%22">Nandy P</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Sukumar+S%22">Sukumar S</searchLink>; CSL Behring, King of Prussia, Pennsylvania, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229216037%22">Journal of the European Academy of Dermatology and Venereology : JEADV</searchLink> [J Eur Acad Dermatol Venereol] 2026 Jul 21. <i>Date of Electronic Publication: </i>2026 Jul 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9216037 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-3083 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209269959%22">09269959 </searchLink><i>NLM ISO Abbreviation: </i>J Eur Acad Dermatol Venereol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42478283 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/jdv.70594 Languages: – Code: eng Text: English Titles: – TitleFull: Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kern JS – PersonEntity: Name: NameFull: Thomsen SF – PersonEntity: Name: NameFull: Kokolakis G – PersonEntity: Name: NameFull: Podda M – PersonEntity: Name: NameFull: Jemec GBE – PersonEntity: Name: NameFull: Gebauer K – PersonEntity: Name: NameFull: Zachariae C – PersonEntity: Name: NameFull: Frew J – PersonEntity: Name: NameFull: Fernandez-Peñas P – PersonEntity: Name: NameFull: Bechara FG – PersonEntity: Name: NameFull: Beissert S – PersonEntity: Name: NameFull: Malandkar S – PersonEntity: Name: NameFull: Scalzo-Inguanti K – PersonEntity: Name: NameFull: Nandy P – PersonEntity: Name: NameFull: Sukumar S IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 07 Text: 2026 Jul 21 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1468-3083 Titles: – TitleFull: Journal of the European Academy of Dermatology and Venereology : JEADV Type: main |
| ResultId | 1 |